Management of hepatocellular carcinoma: An update
2011
Management of Hepatocellular Carcinoma: An Update
publication
Evidence: high
Author Information
Author(s): Jordi Bruix, Morris Sherman
Primary Institution: Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic, University of Barcelona
Conclusion
Hepatocellular carcinoma can now be prevented, detected early, and effectively treated.
Supporting Evidence
- New data on defining HCC risk have emerged for hepatitis B and C.
- Surveillance is cost-effective if the expected HCC risk exceeds 1.5% per year in patients with hepatitis C.
- Complete ablation of lesions smaller than 2 cm is possible in more than 90% of cases.
Takeaway
Doctors have new ways to find and treat liver cancer, making it less deadly than before.
Methodology
The guidelines were updated based on new data regarding surveillance, diagnosis, staging, and treatment of hepatocellular carcinoma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website